Cargando…
PMEPA1 isoform a drives progression of glioblastoma by promoting protein degradation of the Hippo pathway kinase LATS1
The Hippo signaling pathway controls organ development and is also known, in cancer, to have a tumor suppressing role. Within the Hippo pathway, we here demonstrate, in human gliomas, a functional interaction of a transmembrane protein, prostate transmembrane protein, androgen induced 1 (PMEPA1) wit...
Autores principales: | Ji, Jianxiong, Ding, Kaikai, Luo, Tao, Xu, Ran, Zhang, Xin, Huang, Bin, Chen, Anjing, Zhang, Di, Miletic, Hrvoje, Bjerkvig, Rolf, Thorsen, Frits, Wang, Jian, Li, Xingang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989403/ https://www.ncbi.nlm.nih.gov/pubmed/31605013 http://dx.doi.org/10.1038/s41388-019-1050-9 |
Ejemplares similares
-
Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma
por: Han, Mingzhi, et al.
Publicado: (2019) -
Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/β-catenin signalling
por: Han, Mingzhi, et al.
Publicado: (2020) -
TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα
por: Ji, Jianxiong, et al.
Publicado: (2020) -
Trifluoperazine, a novel autophagy inhibitor, increases radiosensitivity in glioblastoma by impairing homologous recombination
por: Zhang, Xin, et al.
Publicado: (2017) -
PMEPA1 Gene Isoforms: A Potential Biomarker and Therapeutic Target in Prostate Cancer
por: Sharad, Shashwat, et al.
Publicado: (2020)